As the executive branch decides how to
address the opioid epidemic, communities hit hardest
by the prescription
drug crisis are beginning to target the pharmaceutical
companies responsible for selling the addictive
drugs.
The symposium we've convened
addresses the ways Organs - on - Chips technology is being used for
drug development
by pharmaceutical
companies and for precision medicine
by clinicians.